Page last updated: 2024-10-24

verapamil and Adolescent Gynecomastia

verapamil has been researched along with Adolescent Gynecomastia in 3 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research Excerpts

ExcerptRelevanceReference
"Gynecomastia is a reaction that is not usually associated with calcium channel blocker therapy."1.27Gynecomastia associated with calcium channel blocker therapy. ( Bosco, LA; Tanner, LA, 1988)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyd, IW1
Deniel Rosanas, J1
Tanner, LA1
Bosco, LA1

Other Studies

3 other studies available for verapamil and Adolescent Gynecomastia

ArticleYear
Adverse Drug Reactions Advisory Committee. Gynaecomastia in association with calcium antagonists.
    The Medical journal of Australia, 1994, Sep-05, Volume: 161, Issue:5

    Topics: Adult; Aged; Calcium Channel Blockers; Diltiazem; Felodipine; Gynecomastia; Humans; Male; Middle Age

1994
[Gynecomastia due to verapamil].
    Medicina clinica, 1994, Mar-19, Volume: 102, Issue:10

    Topics: Gynecomastia; Humans; Hypertension; Male; Middle Aged; Time Factors; Verapamil

1994
Gynecomastia associated with calcium channel blocker therapy.
    Archives of internal medicine, 1988, Volume: 148, Issue:2

    Topics: Aged; Calcium Channel Blockers; Diltiazem; Drug Administration Schedule; Gynecomastia; Humans; Male;

1988